This project seeks to identify and test mechanisms that establish the transcriptional regulatory potency of early
embryos. The relationships among DNA accessibility, nucleosome lability, transcription, histone variants and
DNA sequences interacting with nucleosomes and transcription factors in early embryos and differentiated cell
types will be identified with genomic methods. It is proposed that regulatory potential may be primed at some
transcriptional regulatory elements (TREs, inclusive of promoters and enhancers/silencers) by DNA sequences
promoting weak histone interactions. Such sequence-based priming may synergize with the embryonic
abundance of histone variants known to promote TRE accessibility. In particular, H2A.Z/H3.3 histone variant
nucleosomes associate with low occupancy TREs. Furthermore, H2A.Z mRNA expression is high in blastula
embryos and multipotent adult cell precursors of indirectly developing sea urchins and polychaetes but low in
differentiated cells, therefore supporting a general H2A.Z transcriptional multipotency role. PRO-seq
(Precision Run-On Sequencing, a method to detect actively transcribing TREs) followed by dREG
(Discriminative Regulatory Element Detection, a vector machine TRE prediction tool) will identify
transcriptionally active TREs in early embryos and differentiated adult cell types. OmniATAC experiments will
test if in early embryo and differentiated cell TREs have incipient DNA accessibility. Quantitative micrococcal
nuclease and sequencing (qMNase-seq) will test if TREs with incipient DNA accessibility in early embryos are
occupied by labile nucleosomes. H2A.Z and H3.3 CUT&RUN (Cleavage Under Targets & Release Using
Nuclease) will test the prevalence of these histone variants at labile nucleosomes. The new data sets will
synergize with existing ATAC-seq and PRO-seq characterizations during sea urchin embryogenesis and
differentiation. Comparison among genomic profiles will test if transcriptionally disengaged but accessible
TREs in early embryos associate with labile nucleosomes, H2A.Z, H3.3, A/T-GC sequence periodicities and/or
pioneeer transcription factor binding sites (TFBSs). Similar experiments in terminally differentiated cell types
with low H2A.Z expression will test if incipient accessibility is an inherent property of TREs entirely based on
A/T-GC sequence periodicities. Accessibility sequences setting incipient TRE accessibility during
embryogenesis will be experimentally tested by DNase-I-seq of zygotically microinjected TREs harboring
mutations that alter A/T-GC sequence periodicities or pioneer TFBSs. The project will be integrated with
parallel efforts to implement “research in the classroom” in existing genomic courses that will recruit, train and
motivate diverse undergraduate and graduate students at CUNY. The understanding of basic transcriptional
multipotency mechanisms in sea urchin embryos is relevant to understand the evolution of developmental
gene regulation and to advance future therapeutics of tissue repair and regeneration.
Public Health Relevance Statement
The project will advance the understanding of fundamental regulatory mechanisms that
control embryonic development in a relatively simple invertebrate model system with
favorable experimental advantages. This project is relevant to human and animal
health because the basic mechanisms that control their embryonic processes are
similar. Therefore, this project will facilitate the identification of therapeutic strategies
relevant to modern medicine, particularly in the field of regenerative medicine.
NIH Spending Category
No NIH Spending Category available.
Project Terms
ATAC-seqAdultAnimalsBase PairingBase SequenceBindingBinding SitesBiological ModelsBiologyCell Differentiation processCellsChromatinCleavage Under Targets and Release Using NucleaseConserved SequenceDNADNA SequenceData SetDeoxyribonuclease IDetectionDevelopmentDevelopmental GeneEconomicsEducational process of instructingEmbryoEmbryonic DevelopmentEnhancersEvolutionFutureGene Expression RegulationGenesGenetic TranscriptionGenomeGenomicsGoalsHealthHigh-Throughput Nucleotide SequencingHistone H3.3HistonesHumanInstitutionInvertebratesLytechinus variegatusMentorsMethodsMicrococcal NucleaseModelingModern MedicineMutationNew York CityNucleosomesPhagocytesPopulationPrecision Run-On SequencingPrevalenceProcessPropertyRecruitment ActivityRegenerative MedicineRegulator GenesRegulatory ElementResearchResolutionRoleScientific Advances and AccomplishmentsSea UrchinsSocial MobilityStudentsTestingTherapeuticTrainingUnderrepresented StudentsUniversitiesVariantXCL1 geneblastocystcareercell typechromatin remodelingdesigndetection methoddoctoral studentexperimental studygene regulatory networkgenome-widegenomic profilesgraduate studentmRNA Expressionmutantnovelnucleasepredictive toolspromoterrecruitsocialstudent participationsynergismtissue regenerationtissue repairtranscription factortrendundergraduate research experienceundergraduate studentvector
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
620128079
UEI
L63BKBLD2LH4
Project Start Date
23-September-2024
Project End Date
31-August-2027
Budget Start Date
23-September-2024
Budget End Date
31-August-2027
Project Funding Information for 2024
Total Funding
$378,123
Direct Costs
$250,000
Indirect Costs
$128,123
Year
Funding IC
FY Total Cost by IC
2024
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$378,123
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R15HD115134-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R15HD115134-01
Patents
No Patents information available for 1R15HD115134-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R15HD115134-01
Clinical Studies
No Clinical Studies information available for 1R15HD115134-01
News and More
Related News Releases
No news release information available for 1R15HD115134-01
History
No Historical information available for 1R15HD115134-01
Similar Projects
No Similar Projects information available for 1R15HD115134-01